Effects of Bushen-Jiangya granules on blood pressure and pharmacogenomic evaluation in low-to-medium-risk hypertensive patients: study protocol for a randomized double-blind controlled trial

This study has been approved by the Research Ethics Committee of Guang ’anmen Hospital, China Academy of Chinese Medical Sciences in Beijing, China (No. 2019-186-KY-01). The participants are volunteers, understand the process of this trial, and sign an informed consent. The results of this study will be disseminated to the public through peer-reviewed journals and ac ademic conferences.DiscussionWe hypothesize that patients with low-to-medium-risk hypertension will benefit from BSJY. If successful, this study will provide evidence-based recommendations for clinicians.Trial registrationChinese Clinical Trial Registry ChiMCTR1900002876. Registered in November 2019
Source: Trials - Category: Research Source Type: clinical trials